This is a limited company view. Sign up for a Free Trial to see everything.

Promedior is a clinical-stage biotechnology company pioneering the development of targeted therapeutics to treat diseases involving fibrosis.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Boston

Founded

Employees

22

Stage

Acquired

Total funding

$57M

Last funding

5 years ago

Acquisitions

0

Growth score

47

Mindshare score

43

Scoring

Employee Growth

Use Promedior's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Promedior's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Similar Companies

Prexa Pharmaceuticals

Prexa Pharmaceuticals develops small molecule monoamine reuptake inhibitors as a treatment for ADHD, depression and Parkinson’s disease.
Series B

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes